Versatility of fluorescent nanodiamonds as free radical quantum sensors: from arthritis and metastasis to potential applications in heart diseases

Fluorescent nanodiamonds (FNDs) have emerged as versatile tools in biomedicine due to their unique properties. Synthesized through detonation or high-pressure high-temperature processes, FNDs exhibit superior fluorescence compared to organic dyes, making them ideal for real-time imaging without issues like blinking. The surface chemistry of FNDs, whether hydrophilic or hydrophobic, enhances their versatility for functionalization with macromolecules, facilitating targeted applications. These biologically and chemically inert nanoparticles surpass other fluorescent counterparts in terms of biocompatibility.FNDs, featuring NV-center defects, offer a broad emission spectrum with quantum features, making them suitable for free radical detection. Diamond-based quantum sensing, specifically magnetometry based on T1 relaxometry, allows high-sensitivity detection of free radicals. Free radicals play dual roles in biology, acting as signaling molecules and causing oxidative damage. Oxidative stress, implicated in diseases like cancer and cardiovascular conditions, is challenging to detect due to the short lifetime and low concentration of free radicals.This thesis explores the implementation of diamond-based quantum sensing for in vitro free radical detection in biomedical settings, focusing on arthritis, cancer, and cardiovascular diseases. Chapter 2 investigates free radical levels in synovial fluid from arthritis patients. Chapter 3 examines free radicals during the migration of breast cancer cells, emphasizing the importance of measuring ROS subgroups. In Chapter 4, potential applications of diamond magnetometry in studying redox signaling pathways in cardiac cells are explored, providing a holistic view of free radical biology. The thesis contributes to understanding free radical biology and expands the applications of diamond-based quantum sensing in biomedical research, offering insights into diseases associated with oxidative stress

Versatility of fluorescent nanodiamonds as free radical quantum sensors: from arthritis and metastasis to potential applications in heart diseases

Fluorescent nanodiamonds (FNDs) have emerged as versatile tools in biomedicine due to their unique properties. Synthesized through detonation or high-pressure high-temperature processes, FNDs exhibit superior fluorescence compared to organic dyes, making them ideal for real-time imaging without issues like blinking. The surface chemistry of FNDs, whether hydrophilic or hydrophobic, enhances their versatility for functionalization with macromolecules, facilitating targeted applications. These biologically and chemically inert nanoparticles surpass other fluorescent counterparts in terms of biocompatibility.FNDs, featuring NV-center defects, offer a broad emission spectrum with quantum features, making them suitable for free radical detection. Diamond-based quantum sensing, specifically magnetometry based on T1 relaxometry, allows high-sensitivity detection of free radicals. Free radicals play dual roles in biology, acting as signaling molecules and causing oxidative damage. Oxidative stress, implicated in diseases like cancer and cardiovascular conditions, is challenging to detect due to the short lifetime and low concentration of free radicals.This thesis explores the implementation of diamond-based quantum sensing for in vitro free radical detection in biomedical settings, focusing on arthritis, cancer, and cardiovascular diseases. Chapter 2 investigates free radical levels in synovial fluid from arthritis patients. Chapter 3 examines free radicals during the migration of breast cancer cells, emphasizing the importance of measuring ROS subgroups. In Chapter 4, potential applications of diamond magnetometry in studying redox signaling pathways in cardiac cells are explored, providing a holistic view of free radical biology. The thesis contributes to understanding free radical biology and expands the applications of diamond-based quantum sensing in biomedical research, offering insights into diseases associated with oxidative stress

Quantum Sensing for Real-Time Monitoring of Drug Efficacy in Synovial Fluid from Arthritis Patients

Diamond-based T1 relaxometry is a new technique that allows nanoscale magnetic resonance measurements. Here we present its first application in patient samples. More specifically, we demonstrate that relaxometry can determine the free radical load in samples from arthritis patients. We found that we can clearly differentiate between osteoarthritis and rheumatoid arthritis patients in both the synovial fluid itself and cells derived from it. Furthermore, we tested how synovial fluid and its cells respond to piroxicam, a common nonsteroidal anti-inflammatory drug (NSAID). It is known that this drug leads to a reduction in reactive oxygen species production in fibroblast-like synoviocytes (FLS). Here, we investigated the formation of free radicals specifically. While FLS from osteoarthritis patients showed a drastic decrease in the free radical load, cells from rheumatoid arthritis retained a similar radical load after treatment. This offers a possible explanation for why piroxicam is more beneficial for patients with osteoarthritis than those with rheumatoid arthritis.</p

Quantum Sensing for Real-Time Monitoring of Drug Efficacy in Synovial Fluid from Arthritis Patients

Diamond-based T1 relaxometry is a new technique that allows nanoscale magnetic resonance measurements. Here we present its first application in patient samples. More specifically, we demonstrate that relaxometry can determine the free radical load in samples from arthritis patients. We found that we can clearly differentiate between osteoarthritis and rheumatoid arthritis patients in both the synovial fluid itself and cells derived from it. Furthermore, we tested how synovial fluid and its cells respond to piroxicam, a common nonsteroidal anti-inflammatory drug (NSAID). It is known that this drug leads to a reduction in reactive oxygen species production in fibroblast-like synoviocytes (FLS). Here, we investigated the formation of free radicals specifically. While FLS from osteoarthritis patients showed a drastic decrease in the free radical load, cells from rheumatoid arthritis retained a similar radical load after treatment. This offers a possible explanation for why piroxicam is more beneficial for patients with osteoarthritis than those with rheumatoid arthritis.</p

Quantum Sensing for Real-Time Monitoring of Drug Efficacy in Synovial Fluid from Arthritis Patients

Diamond-based T1 relaxometry is a new technique that allows nanoscale magnetic resonance measurements. Here we present its first application in patient samples. More specifically, we demonstrate that relaxometry can determine the free radical load in samples from arthritis patients. We found that we can clearly differentiate between osteoarthritis and rheumatoid arthritis patients in both the synovial fluid itself and cells derived from it. Furthermore, we tested how synovial fluid and its cells respond to piroxicam, a common nonsteroidal anti-inflammatory drug (NSAID). It is known that this drug leads to a reduction in reactive oxygen species production in fibroblast-like synoviocytes (FLS). Here, we investigated the formation of free radicals specifically. While FLS from osteoarthritis patients showed a drastic decrease in the free radical load, cells from rheumatoid arthritis retained a similar radical load after treatment. This offers a possible explanation for why piroxicam is more beneficial for patients with osteoarthritis than those with rheumatoid arthritis.</p

Quantum Sensing for Real-Time Monitoring of Drug Efficacy in Synovial Fluid from Arthritis Patients

Diamond-based T1 relaxometry is a new technique that allows nanoscale magnetic resonance measurements. Here we present its first application in patient samples. More specifically, we demonstrate that relaxometry can determine the free radical load in samples from arthritis patients. We found that we can clearly differentiate between osteoarthritis and rheumatoid arthritis patients in both the synovial fluid itself and cells derived from it. Furthermore, we tested how synovial fluid and its cells respond to piroxicam, a common nonsteroidal anti-inflammatory drug (NSAID). It is known that this drug leads to a reduction in reactive oxygen species production in fibroblast-like synoviocytes (FLS). Here, we investigated the formation of free radicals specifically. While FLS from osteoarthritis patients showed a drastic decrease in the free radical load, cells from rheumatoid arthritis retained a similar radical load after treatment. This offers a possible explanation for why piroxicam is more beneficial for patients with osteoarthritis than those with rheumatoid arthritis.</p

Quantum Sensing for Real-Time Monitoring of Drug Efficacy in Synovial Fluid from Arthritis Patients

Diamond-based T1 relaxometry is a new technique that allows nanoscale magnetic resonance measurements. Here we present its first application in patient samples. More specifically, we demonstrate that relaxometry can determine the free radical load in samples from arthritis patients. We found that we can clearly differentiate between osteoarthritis and rheumatoid arthritis patients in both the synovial fluid itself and cells derived from it. Furthermore, we tested how synovial fluid and its cells respond to piroxicam, a common nonsteroidal anti-inflammatory drug (NSAID). It is known that this drug leads to a reduction in reactive oxygen species production in fibroblast-like synoviocytes (FLS). Here, we investigated the formation of free radicals specifically. While FLS from osteoarthritis patients showed a drastic decrease in the free radical load, cells from rheumatoid arthritis retained a similar radical load after treatment. This offers a possible explanation for why piroxicam is more beneficial for patients with osteoarthritis than those with rheumatoid arthritis.</p

Quantum Sensing for Real-Time Monitoring of Drug Efficacy in Synovial Fluid from Arthritis Patients

Diamond-based T1 relaxometry is a new technique that allows nanoscale magnetic resonance measurements. Here we present its first application in patient samples. More specifically, we demonstrate that relaxometry can determine the free radical load in samples from arthritis patients. We found that we can clearly differentiate between osteoarthritis and rheumatoid arthritis patients in both the synovial fluid itself and cells derived from it. Furthermore, we tested how synovial fluid and its cells respond to piroxicam, a common nonsteroidal anti-inflammatory drug (NSAID). It is known that this drug leads to a reduction in reactive oxygen species production in fibroblast-like synoviocytes (FLS). Here, we investigated the formation of free radicals specifically. While FLS from osteoarthritis patients showed a drastic decrease in the free radical load, cells from rheumatoid arthritis retained a similar radical load after treatment. This offers a possible explanation for why piroxicam is more beneficial for patients with osteoarthritis than those with rheumatoid arthritis.</p